Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
LIAN | LianBio | Poukalov Konstantin | Director | Feb 15, 2024 | Option Exercise | $3.30 | 55,518 | 182,954 | 36,300 | Feb 20, 2024, 05:27 PM | |
LABP | Landos Biopharma, Inc. | Poukalov Konstantin | Director | Feb 05, 2021 | Buy | $11.14 | 27,453 | 305,826 | 14,647,181 | Feb 09, 2021, 07:56 PM | |
LABP | Landos Biopharma, Inc. | Poukalov Konstantin | Director | Feb 08, 2021 | Buy | $12.21 | 123,053 | 1,503,061 | 14,770,234 | Feb 09, 2021, 07:56 PM | |
LABP | Landos Biopharma, Inc. | Poukalov Konstantin | Director | Feb 09, 2021 | Buy | $14.08 | 99,681 | 1,403,559 | 14,869,915 | Feb 09, 2021, 07:56 PM | |
LABP | Landos Biopharma, Inc. | Poukalov Konstantin | Director | Feb 08, 2021 | Buy | $16.00 | 1,250,000 | 20,000,000 | 14,619,728 | Feb 08, 2021, 06:08 PM | |
KDMN | Kadmon Holdings, Inc. | Poukalov Konstantin | EVP, Chief Financial Officer | Nov 11, 2016 | Buy | $5.81 | 4,000 | 23,250 | 4,000 | Nov 14, 2016, 08:41 AM |